TRIACIN-C bulk active fine chemical vendors

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
Starshine Chemical	⤷ Get Started Free	2023-05-19B1480	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: November 22, 2025

Introduction

Triacin-C is a combination pharmaceutical formulation that primarily contains chloramphenicol and trimethoprim, used predominantly for bacterial infections. As with all APIs, securing a reliable, high-quality bulk source is vital for pharmaceutical manufacturers to ensure consistent product efficacy, regulatory compliance, and cost efficiency. This article reviews the global landscape of API suppliers for Triacin-C, emphasizing key quality standards, sourcing considerations, and industry trends to inform strategic procurement decisions.

Understanding the API Components of TRIACIN-C

Triacin-C combines two active ingredients:

Chloramphenicol: A broad-spectrum antibiotic effective against various Gram-positive and Gram-negative bacteria.
Trimethoprim: An antibacterial agent often combined with sulfonamides but used here in synergy with chloramphenicol.

The API sourcing process involves sourcing these components individually from reputable manufacturers and ensuring their compatibility when combined in the final dosage form.

Global API Supply Landscape for Chloramphenicol

Manufacturers and Suppliers

The API market for chloramphenicol historically revolves around a handful of key suppliers globally, concentrated in Asia, Europe, and North America:

Suzhou China Resources Pharmaceutical Co., Ltd. (China)
One of the prominent Chinese manufacturers with GMP certification, offering high-purity chloramphenicol for export.
Qingdao Bort Medical Technology Co., Ltd. (China)
Provides chloramphenicol API with consistent quality, with certifications to meet international standards.
ICASA (India)
An established Indian API producer with a presence in chloramphenicol manufacturing, supplying to both domestic and international markets, often with competitive pricing.
Fujifilm Toyama Chemical Co., Ltd. (Japan)
A notable supplier with stringent quality controls, though primarily focused on finished dosage products, they also contribute to the API supply ecosystem.
BASF (Europe)
While historically involved in antibiotics, BASF’s focus on high-grade pharmaceuticals supports APIs with excellent purity profiles, including chloramphenicol, for regulated markets.

Quality and Regulatory Standards

Suppliers must comply with Good Manufacturing Practices (GMP), ISO standards, and possess relevant certificates such as EDQM certificates of suitability or FDA approvals. Quality assurance is essential due to chloramphenicol’s potential toxicity, requiring rigorous impurity profiling and contaminant controls.

API Sources of Trimethoprim

Leading API Manufacturers

Venture Chemicals (India)
A significant player with a robust GMP-compliant production facility, offering trimethoprim API adherent to international pharmacopoeial standards.
Hubei Huiming Pharmaceutical Co., Ltd. (China)
Implements strict manufacturing controls, supplying trimethoprim with proven bioavailability and impurity profiles suitable for pharmaceutical use.
KP Biosciences (India)
Supplies high-purity trimethoprim with comprehensive quality certifications, often serving as a cost-effective alternative for bulk procurement.
Ming Keung Chemical (China)
Focuses on antibiotic APIs, including trimethoprim, with a growing export footprint verified by global regulatory agencies.

Considerations for Sourcing Triangle

Manufacturers often source trimethoprim and chloramphenicol from the same region or supplier groups to streamline quality control and logistics. Combining APIs from trusted sources minimizes the risk of cross-contamination, impurity variability, and delayed regulatory approvals.

Key Sourcing Factors for TRIACIN-C APIs

Regulatory Compliance and Certifications

GMP Certification: Ensures manufacturing adherence to quality standards suitable for pharmaceutical API production.
Pharmacopoeia Compliance: APIs must meet USP, EP, or JP standards, depending on the market.
Certificate of Analysis (CoA): Suppliers should provide detailed CoAs reflecting impurity profiles, residual solvents, and stability data.
FDA/EMA Approvals: Particularly for APIs intended for markets with stringent regulatory oversight.

Quality Assurance and Impurity Profile

Given chloramphenicol’s toxicity potential, including bone marrow suppression, API suppliers must provide comprehensive impurity testing—specifically, for chloramphenicol-related impurities such as nitroso chloramphenicol and chloramphenicol-related side-products.

Cost and Lead Time

Competitive pricing is critical, particularly from Chinese and Indian suppliers. However, lead times must align with production schedules, and suppliers with reliable logistics networks are preferred for just-in-time procurement.

Emerging Trends and Industry Dynamics

Shift Towards High-Quality API Supply Chains

Regulatory agencies are increasingly scrutinizing API quality, prompting manufacturers to seek suppliers with proven GMP compliance and robust quality management systems. Many firms are investing in upstream control, including in-house quality laboratories and supply chain audits.

Adoption of Digital Traceability and Transparency

Digital platforms enabling real-time tracking of API batch quality status and compliance documentation are becoming standard, especially for APIs used in high-risk medicines like antibiotics.

Impact of Geopolitical Factors

Trade tensions and import/export restrictions can affect API procurement. Diversification of supply sources across regions reduces dependency and risk exposure.

Conclusion

Sourcing high-quality APIs for TRIACIN-C demands diligent supplier evaluation based on regulatory compliance, quality standards, purity profiles, and logistics reliability. Globally, suppliers from China and India dominate bulk API manufacturing, offering cost-effective options with suitable certifications. European and Japanese producers often provide higher assurance of regulatory compliance, suitable for strict markets. Effective procurement strategies balance quality with cost and lead time, underpinning the successful manufacturing and distribution of TRIACIN-C.

Key Takeaways

Prioritize GMP-certified suppliers, especially for chloramphenicol and trimethoprim APIs, to ensure safety and compliance.
Verify ISO and pharmacopoeial standards for impurity profiles and purity levels to mitigate toxicity risks.
Consider regional diversification of suppliers to reduce supply chain disruptions and geopolitical risks.
Leverage digital transparency tools for real-time quality monitoring, ensuring supply chain integrity.
Align sourcing strategies with regulatory market requirements, especially for regions with stringent drug approval processes.

FAQs

1. What are the primary regions producing API for TRIACIN-C?
Major API producers for TRIACIN-C components are concentrated in China and India, with select European and Japanese manufacturers providing high-grade APIs for regulated markets.

2. How do quality standards differ between Chinese and European API suppliers?
European suppliers typically adhere to stricter GMP guidelines and possess comprehensive certifications like EDQM, whereas Chinese suppliers are increasingly aligning with international standards but vary in regulatory oversight.

3. What are critical quality considerations for chloramphenicol API?
Impurity profiles, residual solvents, endotoxin levels, and stability are critical. Due to toxicity concerns, impurity control is paramount.

4. Can API sourcing impact drug approval in regulated markets?
Yes. Substandard APIs can lead to regulatory rejection, product recalls, or safety concerns, emphasizing the importance of compliant, high-quality sourcing.

5. How has the global API supply chain evolved post-pandemic?
There's heightened focus on supply chain resilience, digital traceability, and diversification of sources to prevent shortages and ensure supply continuity.

References

World Health Organization. (2021). API Quality Standards.
U.S. Pharmacopeia. (2022). Monograph Standards for Chloramphenicol.
European Pharmacopoeia. (2022). API Certification Guidelines.
Market Intelligence Reports. (2023). Global Antibiotic API Manufacturing.
Regulatory Agency Publications. (2022). Good Manufacturing Practice Requirements.

Bulk Pharmaceutical API Sources for TRIACIN-C